Gil Blum
Stock Analyst at Needham
(4.57)
# 924
Out of 4,339 analysts
684
Total ratings
41.4%
Success rate
12.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RNAC Cartesian Therapeutics | Maintained: Buy | $42 → $40 | $6.45 | +520.16% | 35 | May 26, 2026 | |
| CELC Celcuity | Maintained: Buy | $157 | $134.26 | +16.94% | 31 | May 15, 2026 | |
| NRIX Nurix Therapeutics | Maintained: Buy | $26 | $17.38 | +49.60% | 44 | May 15, 2026 | |
| SLDB Solid Biosciences | Reiterated: Buy | $19 | $6.88 | +176.16% | 7 | May 14, 2026 | |
| AUTL Autolus Therapeutics | Maintained: Buy | $10 | $1.68 | +495.24% | 50 | May 14, 2026 | |
| FATE Fate Therapeutics | Maintained: Hold | $2.25 | $2.15 | +4.65% | 21 | May 13, 2026 | |
| NKTX Nkarta | Rated: Buy | $11 | $3.06 | +259.48% | 22 | May 13, 2026 | |
| MREO Mereo BioPharma Group | Maintained: Buy | $3 | $0.3337 | +799.01% | 34 | May 12, 2026 | |
| ARTV Artiva Biotherapeutics | Reiterated: Buy | $18 → $41 | $7.67 | +434.55% | 14 | May 12, 2026 | |
| RCKT Rocket Pharmaceuticals | Maintained: Hold | n/a | $3.00 | - | 49 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $5.28 | +32.58% | 12 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $16.67 | - | 55 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $8 | $2.97 | +169.36% | 29 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $16.32 | +169.69% | 3 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $1.28 | +212.50% | 35 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $5.59 | +114.67% | 47 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 | $29.41 | +155.02% | 21 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $1.07 | +460.75% | 16 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $82 | $51.59 | +58.95% | 40 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $6.11 | - | 28 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.86 | - | 25 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.01 | n/a | 15 | Dec 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | kr 400.00 → kr 371.00 | $197.00 | n/a | 16 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $29.93 | n/a | 14 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $73.65 | n/a | 10 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 6 | Jun 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.0001 | n/a | 5 | Apr 6, 2022 |
Cartesian Therapeutics
May 26, 2026
Maintained: Buy
Price Target: $42 → $40
Current: $6.45
Upside: +520.16%
Celcuity
May 15, 2026
Maintained: Buy
Price Target: $157
Current: $134.26
Upside: +16.94%
Nurix Therapeutics
May 15, 2026
Maintained: Buy
Price Target: $26
Current: $17.38
Upside: +49.60%
Solid Biosciences
May 14, 2026
Reiterated: Buy
Price Target: $19
Current: $6.88
Upside: +176.16%
Autolus Therapeutics
May 14, 2026
Maintained: Buy
Price Target: $10
Current: $1.68
Upside: +495.24%
Fate Therapeutics
May 13, 2026
Maintained: Hold
Price Target: $2.25
Current: $2.15
Upside: +4.65%
Nkarta
May 13, 2026
Rated: Buy
Price Target: $11
Current: $3.06
Upside: +259.48%
Mereo BioPharma Group
May 12, 2026
Maintained: Buy
Price Target: $3
Current: $0.3337
Upside: +799.01%
Artiva Biotherapeutics
May 12, 2026
Reiterated: Buy
Price Target: $18 → $41
Current: $7.67
Upside: +434.55%
Rocket Pharmaceuticals
May 8, 2026
Maintained: Hold
Price Target: n/a
Current: $3.00
Upside: -
May 8, 2026
Reiterated: Buy
Price Target: $7
Current: $5.28
Upside: +32.58%
May 7, 2026
Maintained: Sell
Price Target: n/a
Current: $16.67
Upside: -
May 7, 2026
Rated: Buy
Price Target: $8
Current: $2.97
Upside: +169.36%
May 7, 2026
Reiterated: Buy
Price Target: $44
Current: $16.32
Upside: +169.69%
May 6, 2026
Maintained: Buy
Price Target: $4
Current: $1.28
Upside: +212.50%
May 6, 2026
Reiterated: Buy
Price Target: $12
Current: $5.59
Upside: +114.67%
May 6, 2026
Maintained: Buy
Price Target: $75
Current: $29.41
Upside: +155.02%
May 6, 2026
Maintained: Buy
Price Target: $6
Current: $1.07
Upside: +460.75%
May 5, 2026
Maintained: Buy
Price Target: $82
Current: $51.59
Upside: +58.95%
Nov 7, 2025
Maintained: Hold
Price Target: n/a
Current: $6.11
Upside: -
Oct 24, 2025
Rated: Hold
Price Target: n/a
Current: $1.86
Upside: -
Dec 27, 2024
Rated: Hold
Price Target: n/a
Current: $7.01
Upside: n/a
Feb 16, 2023
Reiterated: Buy
Price Target: kr 400.00 → kr 371.00
Current: $197.00
Upside: n/a
Dec 7, 2022
Maintained: Buy
Price Target: $6
Current: $29.93
Upside: n/a
Aug 25, 2022
Rated: Hold
Price Target: n/a
Current: $73.65
Upside: n/a
Jun 3, 2022
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Apr 6, 2022
Reiterated: Buy
Price Target: $6
Current: $0.0001
Upside: n/a